Global & Public Health (all articles)
Report: Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic
9 Dec, 2020 | 08:20h | UTC
Another randomized trial shows hydroxychloroquine is not effective as postexposure prophylaxis to prevent Covid-19
9 Dec, 2020 | 08:19h | UTCSummary for patients: Summary for Patients: Postexposure Hydroxychloroquine Prophylaxis to Prevent SARS-CoV-2 Infection
New vaccine data is coming: Watch out for these 3 claims
9 Dec, 2020 | 08:17h | UTCNew Vaccine Data Is Coming: Watch Out for These 3 Claims – Wired
Review: Cardiopulmonary impact of particulate air pollution in high-risk populations
9 Dec, 2020 | 08:07h | UTC
If exposed to Covid-19, how long before you have symptoms? Median incubation is 5.1 days, and 97.5% of those who develop symptoms do so within 11.5 days of being exposed to the virus
8 Dec, 2020 | 08:06h | UTCIf Exposed To Covid-19 Coronavirus, How Long Before You Have Symptoms – Forbes
WHO Manifesto: Prescriptions and actionables for a healthy and green recovery from Covid-19
8 Dec, 2020 | 08:13h | UTCWHO manifesto for a healthy recovery from COVID-19 – World Health Organization
Commentary on Twitter
The WHO Manifesto for a healthy recovery from #COVID19 lists 6⃣ steps to create a healthier ?, fairer ⚖️ & greener ? world while investing to maintain & resuscitate the economy:
?https://t.co/Ftv0KCKsMA pic.twitter.com/PBuejrb7B4
— World Health Organization (WHO) (@WHO) July 31, 2020
WHO set to approve a COVID-19 vaccine by the end of 2020—increasing hopes for equitable access
8 Dec, 2020 | 08:09h | UTC
Opinion: “Get ready for vaccine false side effects”. When millions of people are vaccinated, naturally occurring health problems could be wrongly attributed to vaccines
8 Dec, 2020 | 07:55h | UTCGet Ready for False Side Effects – Science Translational Medicine
Data from 45 countries show containing COVID vs. saving the economy is a false dichotomy
8 Dec, 2020 | 07:57h | UTC
First-of-its-kind African trial tests common drugs to prevent severe COVID-19. “Could cheap, widely available drugs prevent patients with mild illness from becoming severely sick?”
8 Dec, 2020 | 07:46h | UTCFirst-of-its-kind African trial tests common drugs to prevent severe COVID-19 – Science
New CDC Guidance with 10 public health strategies to address high levels of community transmission of SARS-Cov-2, including universal use of face masks
7 Dec, 2020 | 01:10h | UTCCommentaries: Masks are critical to stopping coronavirus spread, even at home, CDC says – CNN AND CDC recommends ‘universal’ use of face masks to prevent COVID-19 spread – UPI
Commentary on Twitter
In most of the US, Covid transmission is at dangerously high levels. CDC released a new package of 10 key strategies needed to curb the spread, including universal masking and postponing travel. https://t.co/b0utHmygSI pic.twitter.com/HXjlo89WrR
— Dr. Tom Frieden (@DrTomFrieden) December 5, 2020
WHO Guidance for improving acceptance and uptake of COVID-19 vaccines
7 Dec, 2020 | 01:16h | UTCCommentary: Guidance For Improving Vaccine Uptake Published By WHO TAG – Health Policy Watch
The UK has approved a COVID vaccine — but scientists still have many questions. One of them is if the vaccines will prevent the transmission of the disease
7 Dec, 2020 | 00:52h | UTCThe UK has approved a COVID vaccine — here’s what scientists now want to know – Nature
Despite vaccinations, COVID-19 death toll likely to increase into April
7 Dec, 2020 | 00:57h | UTC
Study in Germany comparing regions with vs. without mask mandates concluded that 20 d after becoming mandatory, face masks reduced new Covid-19 infections by around 45%
7 Dec, 2020 | 00:46h | UTC
Case-control study: Meningococcus B vaccine prevents disease with 79 percent effectiveness in children and young adults
6 Dec, 2020 | 23:48h | UTCCommentary: Meningococcus B vaccine prevents disease with 79 per cent effectiveness in under-18s – University of Bristol
Commentary on Twitter
In this matched case-control study, children who developed meningococcal disease were less likely to have been vaccinated with 4CMenB vs matched controls without meningococcal disease during the first 5y of vaccine availability in Portugal https://t.co/dGagZ3aTIB @adamhfinn
— JAMA (@JAMA_current) December 3, 2020
New WHO Guidance on masks for the public and health workers in the context of COVID-19
4 Dec, 2020 | 08:24h | UTCMask use in the context of COVID-19 – World Health Organization
Commentaries: WHO fine-tunes advice on COVID masks for public, health workers – Reuters AND WHO updates mask advice, recommending they be worn in indoor, poorly ventilated areas – CBC
Commentary on Twitter
.@WHO has tightened its guidance on face masks, recommending that where COVID-19 is spreading, masks be worn by everyone in healthcare settings, indoor low ventilated areas & outdoors when a distance of 3 ft from others cannot be maintained. #MaskUpAmerica https://t.co/dJUJ2syDMN
— IDSA (@IDSAInfo) December 3, 2020
The 2020 report of The Lancet Countdown on health and climate change: responding to converging crises
4 Dec, 2020 | 08:27h | UTCEditorial: Climate and COVID-19: converging crises
Commentaries: No country is immune from climate-change health impacts – University of Washington AND Feeling the heat? Scientists warn of climate shocks to global health – Reuters AND ‘We Don’t Have To Live This Way’: Doctors Call For Climate Action – NPR
Commentary on Twitter
NEW—No country is immune from health impacts of worsening climate change. Unless urgent action is taken, #climatechange will threaten global health, disrupt lives & livelihoods, & overwhelm health-care systems: 2020 @LancetCountdown report #LancetClimate20 https://t.co/gSdm1plfNj pic.twitter.com/SeOrI2sTw1
— The Lancet (@TheLancet) December 2, 2020
Why the CDC changed its Covid-19 quarantine guidelines
4 Dec, 2020 | 08:18h | UTCWhy the CDC changed its Covid-19 quarantine guidelines – Vox
CDC Guideline: Duration of Isolation and Precautions for Adults with COVID-19 – Centers for Disease Control and Prevention
Perspective: Why most countries won’t benefit from Moderna and Pfizer’s Covid-19 vaccines
4 Dec, 2020 | 08:14h | UTCWhy Most Countries Won’t Benefit From Moderna And Pfizer’s Covid-19 Vaccines – Forbes
Moderna vaccine: Antibody levels persist for at least 4 months
4 Dec, 2020 | 08:16h | UTCDurability of Responses after SARS-CoV-2 mRNA-1273 Vaccination – New England Journal of Medicine
China has promised millions of coronavirus vaccines to countries globally. And it is ready to deliver them.
4 Dec, 2020 | 08:12h | UTC
WHO looks at possible ‘e-vaccination certificates’ for travel
4 Dec, 2020 | 08:09h | UTCWHO looks at possible ‘e-vaccination certificates’ for travel – Reuters
UK becomes first country to authorize Pfizer/BioNTech’s Covid-19 vaccine, first shots roll out next week
3 Dec, 2020 | 08:44h | UTCPress release: UK medicines regulator gives approval for first UK COVID-19 vaccine – Medicines and Healthcare products Regulatory Agency
See also: Covid-19: Pfizer/BioNTech vaccine judged safe for use in UK – BBC AND Expert reaction to news that the MHRA has approved the Pfizer/BioNTech COVID-19 vaccine for mass UK roll out – Science Media Centre AND UK approves Pfizer/BioNTech Covid vaccine for rollout next week – The Guardian
WHO Solidarity Trial: Remdesivir, hydroxychloroquine, lopinavir, and interferon regimens had little or no effect on hospitalized patients with Covid-19
3 Dec, 2020 | 08:47h | UTCAudio Interview: Caring for Hospitalized Patients with Covid-19
Commentary on Twitter (thread – click for more)
The biggest multinational pandemic randomised trial #SOLIDARITYtrial published in the New England Journal of Medicine. https://t.co/VbpbpziFwm
WHO, trial leaders, numerous countries, hospitals, doctors, nurses, patients & many others are to be congratulated!
Key results ?? 1/5 pic.twitter.com/Xe9K6EfUpc
— Kari Tikkinen (@KariTikkinen) December 2, 2020